|
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
![]() |
||||||||||||||||||||||||||||||||||||
| Sponsor: | National Center for Research Resources (NCRR) |
|---|---|
| Information provided by: | National Center for Research Resources (NCRR) |
| ClinicalTrials.gov Identifier: | NCT00000107 |
Purpose
Adults with cyanotic congenital heart disease have elevated levels of plasma proatrial natruretic peptide (proANP) which most likely results in chronic dehydration, leading to reduced oxygen transport to tissues and shortness of breath with activity. The purpose of this study is to characterize adults with cyanotic congenital heart defects with respect to their body composition (water and fat-free mass) and resting metabolic rates. The study consists of several measures of how much body water, fat and lean tissue a subject has, and measures the number of calories the subject's body uses at rest. Adult subjects with cyanotic congenital heart disease will be recruited along with healthy noncyanotic control subjects matched for age, gender, and body weight.
| Condition |
|---|
|
Heart Defects, Congenital |
| Study Type: | Observational |
| Study Design: | Observational Model: Case Control Observational Model: Natural History |
Eligibility| Ages Eligible for Study: | 17 Years to 60 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
Contacts and Locations
More Information
| ClinicalTrials.gov Identifier: | NCT00000107 History of Changes |
| Other Study ID Numbers: | NCRR-M01RR00109-0737, M01RR00109 |
| Study First Received: | January 18, 2000 |
| Last Updated: | June 23, 2005 |
| Health Authority: | United States: Federal Government |
|
Cyanotic Congenital Heart Disease |
|
Congenital Abnormalities Heart Defects, Congenital Heart Diseases Cardiovascular Abnormalities Cardiovascular Diseases |